Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $83.4100 (1.19%) ($83.4100 - $84.6400) on Mon. May. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 40 | Latest Price | $83.4100(1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWO(56%) IBB(55%) IWM(55%) IWC(54%) IWN(54%) | Factors Impacting LGND price | LGND will decline at least -1.8% in a week (0% probabilities). UUP(-19%) VIXM(-18%) VXX(-16%) TBT(-8%) UNG(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $87.54 | 5 Day Moving Average | $84.38(-1.15%) | 10 Day Moving Average | $83.74(-0.39%) | 20 Day Moving Average | $87.54(-4.72%) | To recent high | -30.8% | To recent low | 5.8% | Market Cap | $1.34b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |